Background: Asthma is the most common chronic disease in childhood and places a significant burden on public and private health systems. This retrospective cohort analysis utilised administrative healthcare claims data (US Clinformatics™ Multiplan database; compliant with the US Department of Health & Human Services Health Insurance Portability and Accountability Act) to characterise asthma exacerbations requiring intervention in a US paediatric patient population. Methods: Patients aged > 1–17 years with a recorded asthma diagnosis and receiving treatment were identified in the US Clinformatics™ Multiplan database over a 9-year period (2004–2012). Both incident and prevalent cases of asthma were included, with the most recently recorded asthma diagnosis designated as the index date. The 12-month period following the index date was analysed for asthma exacerbations, defined as an event requiring treatment with systemic corticosteroid or resulting in an asthma-related hospitalisation or emergency department visit. Results: Data from 734,114 children with asthma (41.5 % females, 58.5 % males) were analysed, of this cohort 34.4 % experienced ≥ 1 exacerbation during the follow-up period. The proportion who experienced ≥ 1 exacerbation increased from 28.9 % in 2004 to 36.3 % in 2012, based on the reported index date. Their mean annual exacerbation frequency was 1.4; 85.8 % of exacerbations were defined by systemic corticosteroids use. A consistent trend of increased exacerbation incidence in the fall and early winter was observed, in particular exacerbations defined by systemic corticosteroid use. A greater proportion of asthma-related hospitalisations were associated with younger age. Conclusions: Approximately one-third of children experienced ≥ 1 exacerbation in real-world clinical practice. A targeted treatment approach with a focus on those with a history of recurrent exacerbations is recommended to improve asthma control. This targeted approach could also minimise the frequent systemic corticosteroid exposure particularly at an early age when side effects of systemic corticosteroids are more pronounced.
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1X68g0B
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2020
(289)
- ► Φεβρουαρίου (28)
-
►
2019
(9071)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (3642)
- ► Ιανουαρίου (3200)
-
►
2018
(39872)
- ► Δεκεμβρίου (3318)
- ► Σεπτεμβρίου (3683)
- ► Φεβρουαρίου (2693)
- ► Ιανουαρίου (3198)
-
►
2017
(41099)
- ► Δεκεμβρίου (3127)
- ► Σεπτεμβρίου (2173)
-
▼
2016
(13807)
- ► Δεκεμβρίου (700)
- ► Σεπτεμβρίου (600)
-
▼
Ιουνίου
(1110)
-
▼
Ιουν 05
(50)
- The impact of marital status at diagnosis on cance...
- Genetic alterations of differentiated thyroid carc...
- Sorafenib treatment in children with relapsed and ...
- Incidence and long-term outcome of postradiotherap...
- Effects of propolis and gamma-cyclodextrin on inte...
- Study Skills Inventory among Medical Students of P...
- Inappropriate statistical method in a parallel-gro...
- A feasibility study of implementing grip strength ...
- Effectiveness of management interventions for cont...
- Microenvironmental Control of Adipocyte Fate and F...
- Cellular Organization and Cytoskeletal Regulation ...
- Issue Cover (June 2016)
- Tridimensional finite element analysis of teeth mo...
- Ovarian malignancy unmasked by venous gangrene in ...
- The Trans-Pacific Partnership Agreement and health...
- Retrospective cohort analysis of healthcare claims...
- High tau levels in cerebrospinal fluid predict nur...
- We need to optimize piperacillin-tazobactam dosing...
- Rapid assessment of knowledge, attitudes, practice...
- A prospective multicenter cohort study of frailty ...
- Antiepileptic drug combinations not involving valp...
- The Reliability of Oral and Pharyngeal Dimensions ...
- Extending Aromatase-Inhibitor Adjuvant Therapy to ...
- Extending Aromatase-Inhibitor Adjuvant Therapy to ...
- Extending Aromatase-Inhibitor Adjuvant Therapy to ...
- Changing Adjuvant Breast-Cancer Therapy with a Sig...
- Extending Aromatase-Inhibitor Adjuvant Therapy to ...
- Changing Adjuvant Breast-Cancer Therapy with a Sig...
- A Plea for Ecological Argument Technologies
- Χρόνιος πόνος και υποδοχείς της κανναβινόλης
- Φάρμακα για το λουμπάγκο
- Πόνοι στη μέση
- Πόνοι στη μέση και νευρογλοία
- Οι κανναβινοειδείς υποδοχείς
- Ο ρόλος της γλυκίνης στο λουμπάγκο
- Ο ρόλος της γλουταμάτης στον πόνο
- Health-related quality of life after maxillectomy:...
- Cross-cover of oral and maxillofacial surgery out-...
- Outcomes of treatment of fractures of the frontal ...
- Recording Mouse Ultrasonic Vocalizations to Evalua...
- The concurrent and predictive validity of the Dutc...
- The role of biofilm on orthopaedic implants: the “...
- Neural indices of phonemic discrimination and sent...
- Tumor Necrosis Factor-Like Weak Inducer of Apoptos...
- Errors as a Means of Reducing Impulsive Food Choice
- Assessing stability in mild and moderate Parkinson...
- Is age an independent risk factor for medical comp...
- Apoptosis-associated protein expression in human s...
- TWiV 392: Zika virus!
- Pimavanserin: First Global Approval
-
▼
Ιουν 05
(50)
- ► Φεβρουαρίου (1350)
- ► Ιανουαρίου (1400)
-
►
2015
(1500)
- ► Δεκεμβρίου (1450)
Ετικέτες
Κυριακή 5 Ιουνίου 2016
Retrospective cohort analysis of healthcare claims in the United States characterising asthma exacerbations in paediatric patients
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου